Re: ‘ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies’ by Mikulska et al.

S. Wijetilleka; D. Jayne; C. Mukhtyar; M. Y. Karim

doi:10.1016/j.cmi.2018.12.025

Re: ‘ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies’ by Mikulska et al.

S. Wijetilleka, D. Jayne, C. Mukhtyar, M. Y. Karim

Norwich Medical School

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	531-532
Number of pages	2
Journal	Clinical Microbiology and Infection
Volume	25
Issue number	4
Early online date	27 Dec 2018
DOIs	https://doi.org/10.1016/j.cmi.2018.12.025
Publication status	Published - 1 Apr 2019

Access to Document

10.1016/j.cmi.2018.12.025

https://linkinghub.elsevier.com/retrieve/pii/S1198743X18308152

Cite this

@article{76b80d20044848d5af28eb137dc8a51e,

title = "Re: {\textquoteleft}ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies{\textquoteright} by Mikulska et al.",

author = "S. Wijetilleka and D. Jayne and C. Mukhtyar and Karim, {M. Y.}",

year = "2019",

month = apr,

day = "1",

doi = "10.1016/j.cmi.2018.12.025",

language = "English",

volume = "25",

pages = "531--532",

journal = "Clinical Microbiology and Infection",

issn = "1198-743X",

publisher = "Elsevier",

number = "4",

}

TY - JOUR

T1 - Re: ‘ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies’ by Mikulska et al.

AU - Wijetilleka, S.

AU - Jayne, D.

AU - Mukhtyar, C.

AU - Karim, M. Y.

PY - 2019/4/1

Y1 - 2019/4/1

U2 - 10.1016/j.cmi.2018.12.025

DO - 10.1016/j.cmi.2018.12.025

M3 - Letter

VL - 25

SP - 531

EP - 532

JO - Clinical Microbiology and Infection

JF - Clinical Microbiology and Infection

SN - 1198-743X

IS - 4

ER -